Similar articles

• Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.

  Mehta JL. Mehta JL. Clin Cardiol. 1998 Dec;21(12):879-84. doi: 10.1002/clc.4960211204. Clin Cardiol. 1998. PMID: 9853178 Free PMC article. Review.
• How hot is inflammation in acute coronary syndrome?

  Verheugt FW. Verheugt FW. Eur Heart J. 2000 Dec;21(24):1990-2. doi: 10.1053/euhj.2000.2472. Eur Heart J. 2000. PMID: 11102246 No abstract available.
• Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?

  Markuszewski L, Rosiak M, Golanski J, Rysz J, Spychalska M, Watala C. Markuszewski L, et al. Basic Clin Pharmacol Toxicol. 2006 May;98(5):503-9. doi: 10.1111/j.1742-7843.2006.pto_343.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16635110
• Aspirin in the prevention of cardiovascular disease in women.

  Schwartz DJ. Schwartz DJ. N Engl J Med. 2005 Jun 30;352(26):2751-2; author reply 2751-2. doi: 10.1056/NEJM200506303522617. N Engl J Med. 2005. PMID: 15987927 No abstract available.
• Variability in response to aspirin: do we understand the clinical relevance?

  Campbell CL, Steinhubl SR. Campbell CL, et al. J Thromb Haemost. 2005 Apr;3(4):665-9. doi: 10.1111/j.1538-7836.2005.01119.x. Epub 2005 Feb 3. J Thromb Haemost. 2005. PMID: 15703034 Review.